12 research outputs found

    Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry.

    Get PDF
    BACKGROUND: The Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF) is an ongoing prospective noninterventional registry, which is providing important information on the baseline characteristics, treatment patterns, and 1-year outcomes in patients with newly diagnosed non-valvular atrial fibrillation (NVAF). This report describes data from Indian patients recruited in this registry. METHODS AND RESULTS: A total of 52,014 patients with newly diagnosed AF were enrolled globally; of these, 1388 patients were recruited from 26 sites within India (2012-2016). In India, the mean age was 65.8 years at diagnosis of NVAF. Hypertension was the most prevalent risk factor for AF, present in 68.5% of patients from India and in 76.3% of patients globally (P < 0.001). Diabetes and coronary artery disease (CAD) were prevalent in 36.2% and 28.1% of patients as compared with global prevalence of 22.2% and 21.6%, respectively (P < 0.001 for both). Antiplatelet therapy was the most common antithrombotic treatment in India. With increasing stroke risk, however, patients were more likely to receive oral anticoagulant therapy [mainly vitamin K antagonist (VKA)], but average international normalized ratio (INR) was lower among Indian patients [median INR value 1.6 (interquartile range {IQR}: 1.3-2.3) versus 2.3 (IQR 1.8-2.8) (P < 0.001)]. Compared with other countries, patients from India had markedly higher rates of all-cause mortality [7.68 per 100 person-years (95% confidence interval 6.32-9.35) vs 4.34 (4.16-4.53), P < 0.0001], while rates of stroke/systemic embolism and major bleeding were lower after 1 year of follow-up. CONCLUSION: Compared to previously published registries from India, the GARFIELD-AF registry describes clinical profiles and outcomes in Indian patients with AF of a different etiology. The registry data show that compared to the rest of the world, Indian AF patients are younger in age and have more diabetes and CAD. Patients with a higher stroke risk are more likely to receive anticoagulation therapy with VKA but are underdosed compared with the global average in the GARFIELD-AF. CLINICAL TRIAL REGISTRATION-URL: http://www.clinicaltrials.gov. Unique identifier: NCT01090362

    DARN/SuperDARN

    No full text
    International audienceThe Dual Auroral Radar Network (DARN) is a global-scale network of I-IF and VHF radars capable of sensing backscatter from ionospheric irregularities in the E and F-regions of the high-latitude ionosphere. Currently, the network consists of the STARE VHF radar system in northern Scandinavia, a northern-hemisphere, longitudinal chain of HF radars that is funded to extend from Saskatoon, Canada to central Finland, and a southern-hemisphere chain that is funded to include Halley Station, SANAE and Syowa Station in Antarctica. When all of the HF radars have been completed they will operate in pairs with common viewing areas so that the Doppler information contained in the backscattered signals may be combined to yield maps of high-latitude plasma convection and the convection electric field. In this paper, the evolution of DARN and particularly the development of its SuperDARN HF radar element is discussed. The DARN/SuperDARN network is particularly suited to studies of large-scale dynamical processes in the magnetosphere-ionosphere system, such as the evolution of the global configuration of the convection electric field under changing IMF conditions and the development and global extent of large-scale Mi-ID waves in the magnetosphere-ionosphere cavity. A description of the HF radars within SuperDARN is given along with an overview of their existing and intended locations, intended start of operations, Principal Investigators, and sponsoring agencies. Finally, the operation of the DARN experiment within ISTP/GGS, the availability of data, and the form and availability of the Key Parameter files is discussed

    The dynorphin/kappa-opioid system of the brain as a promising target for therapy for dependence on psychoactive substances

    No full text

    Nitric oxide and gamma-aminobutyric acid as regulators of neurogenesis in the brain of adult mammals: Models of seizure activity

    No full text

    A Bibliography of Australian Paediatrics 1846–1900 PART III

    No full text
    corecore